Pharma Journalist - Page 863 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Generon announces the initiation of a Phase 1 Clinical Trial for A-337

LEO Pharma Starts Phase 3 Clinical Study for Tralokinumab in Atopic Dermatitis

SGS Expands Extractables and Leachables Testing Capabilities at its Shanghai Facility

JSR Life Sciences agrees to acquire Selexis SA

Axcella Appoints Tony Tramontin as SVP, Chief Scientific Officer

Arena Pharmaceuticals Appoints Jennifer Jarrett to Board of Directors

Certain genetic faults could help predict success of immunotherapy

Pfizer and Lilly Receive FDA Fast Track Designation for Tanezumab

Numab Therapeutics announces collaboration and option agreement with Kaken Pharma

Astellas and Pfizer Announce Amendment to Clinical Research Protocol for Phase 3 PROSPER Trial of enzalutamide